A testing system capable of simultaneously detecting the coronavirus genome and deciding if it is the Omicron variant of the virus has been developed...
The COVID-globulin medicine against coronavirus based on convalescent blood plasma has successfully passed clinical trials and received a permanent certification by the Russian Health...
The Ministry of Health of the Russian Federation has included the injectable form of the direct-acting antiviral drug Areplivir® (favipiravir) in the updated, fourteenth, version...
New Russian vaccine against the coronavirus, Convacell, can be registered before the end of the first quarter of 2022, head of the Federal Bio-Medical...
The vaccine, called spike ferritin nanoparticle (SpFN), stands out in the COVID-19 vaccine landscape. Scientists developed a nanoparticle vaccine, based on a ferritin platform,...
ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...